Cervical cancer trials in Greece

1 trial · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

  Where

  Athens, Chaïdári

  Age

  18 years and over

  People

  1,023 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT07216703 · EU 2025-521514-26-00